Aegerion Pharma Inc (AEGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 35,387 | 44,530 | 35,716 | 49,003 | 67,303 |
| Cost of Goods | 13,838 | 23,063 | 14,966 | 12,011 | 14,486 |
| Gross Profit | 21,549 | 21,467 | 20,750 | 36,992 | 52,817 |
| Operating Expenses | 41,152 | 60,884 | 80,549 | 65,678 | 55,691 |
| Operating Income | -18,765 | -39,354 | -58,833 | -28,675 | -2,388 |
| Interest Expense | 7,720 | 7,449 | 7,202 | 6,492 | 7,113 |
| Other Income | 165 | 223 | 738 | -410 | 30 |
| Pre-tax Income | -26,320 | -46,580 | -65,297 | -35,577 | -9,471 |
| Income Tax | 246 | 229 | 257 | 1,022 | 294 |
| Net Income Continuous | -26,566 | -46,809 | -65,554 | -36,599 | -9,765 |
| Net Income | $-26,566 | $-46,809 | $-65,554 | $-36,599 | $-9,765 |
| EPS Basic Total Ops | -0.90 | -1.59 | -2.22 | -1.27 | -0.34 |
| EPS Basic Continuous Ops | -0.90 | -1.59 | -2.22 | -1.27 | -0.34 |
| EPS Diluted Total Ops | -0.90 | -1.59 | -2.22 | -1.27 | -0.34 |
| EPS Diluted Continuous Ops | -0.90 | -1.59 | -2.22 | -1.27 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.46 | -0.87 | -1.85 | -0.89 | 0.07 |
| EBITDA(a) | $-13,209 | $-24,207 | $-53,297 | $-23,136 | $3,170 |